Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

19 nov. 2025 04h35 HE | Source: Research and Markets

Human Microbiome Research Report 2025: Market to Reach $1.52 Billion by 2030, Rising at a CAGR of 16.28% - Global Trends, Opportunities, and Forecast, 2020-2030F

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Human Microbiome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
10 nov. 2025 09h31 HE | Source: Research and Markets

United States Peptide Therapeutics (Retail Side) Market Analysis Report 2025: A $77.54 Billion Market by 2030, Driven by a Surge in Demand for GLP-1 Therapies

Dublin, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The "United States Peptide Therapeutics (Retail Side) Market by Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ...
06 nov. 2025 07h00 HE | Source: Treos Bio Corp.

TREOS Bio Announces Publication of Phase 1b Clinical Trial Results of PolyPEPI1018 Plus TAS-102 in Refractory MSS mCRC in JCO Oncology Advances

LONDON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- TREOS Bio today announced the publication in Journal of Clinical Oncology - Oncology Advances of results from OBERTO-201 (NCT05130060), a Phase 1b study...
14 oct. 2025 07h30 HE | Source: Aanastra Inc

Aanastra Inc Announces Presentations of Preclinical Data at Upcoming Conferences in Support of its Lead Programs for Anti-CD19 In Vivo CAR-T (AAN-14x) and In vivo Rescue of P53 Mutations in Tumors (AAN-53x)

Aanastra Inc to present preclinical data for in vivo CAR-T and p53 RNA programs leveraging its proprietary PEP-NP™ peptide delivery technology
28 sept. 2025 22h56 HE | Source: Clinuvel Pharmaceuticals Limited

CLINUVEL to advance novel pharmaceutical formulations in preclinical program

Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug delivery platforms for peptides, melanocortinsaim to predict drug release...
08 sept. 2025 04h46 HE | Source: Research and Markets

Human Microbiome Global Forecast Report 2025 | Market Set to Surge, Reaching USD 7.09 Billion by 2031 Driven by Personalized Medicine Demand

Dublin, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The "Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral,...
27 août 2025 07h00 HE | Source: Treos Bio Corp.

TREOS Bio Partners with Charité Berlin and Junshi Biosciences to Launch Pivotal Phase II Clinical Trial in Refractory MSS Colorectal Cancer

LONDON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- TREOS Bio Ltd., a clinical-stage biotechnology company developing next-generation off-the-shelf peptide cancer immunotherapies, today announced the...
08 août 2025 04h01 HE | Source: Research and Markets

Bio/Pharmaceutical Outsourcing Analysis Report, June 2025 Edition - ADCs on the Rise: MilliporeSigma, Lonza Invest in Manufacturing While BioNTech Adds CMOs Ahead of FDA Filing

Dublin, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The "Bio/Pharmaceutical Outsourcing Report, June 2025" report has been added to ResearchAndMarkets.com's offering.This report gives an important monthly...
23 juil. 2025 09h06 HE | Source: Research and Markets

Bio/Pharmaceutical Outsourcing Report, May 2025 Edition - Discover the Latest Outsourcing Contracts, Opportunities, Threats, Mergers, and Investments

Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "Bio/Pharmaceutical Outsourcing Report, May 2025" report has been added to ResearchAndMarkets.com's offering.The Bio/Pharmaceutical Outsourcing Report...
29 mai 2025 09h08 HE | Source: Research and Markets

Bio/Pharmaceutical Outsourcing Market Analysis Report, April 2025 Edition - Biosimilar Approvals Surge to Record High, A Key Opportunity for Biologic CMOs

Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "Bio/Pharmaceutical Outsourcing Report, April 2025" has been added to ResearchAndMarkets.com's offering. The Bio/Pharmaceutical Outsourcing Report...

Page précédente

Page suivante